OTCM
AUVPQ
Market cap1kUSD
May 19, Last price
0.00USD
IPO
-99.95%
Name
Applied UV Inc
Chart & Performance
P/E
—
P/S
0.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
55.20%
Rev. gr., 5y
40.05%
Revenues
41m
+102.18%
Net income
-13m
L-40.12%
CFO
-8m
L-10.21%
Profile
Applied UV, Inc., through its subsidiaries, develops, acquires, and commercializes technology that addresses air purification and infection control in the healthcare, hospitality, commercial, municipal, and residential markets in the United States, Canada, and Europe. It operates through Disinfection and Hospitality segments. The company offers science-based solutions and products in air purification under the Airocide brand; and disinfection of hard surfaces under the Lumicide brand. It also manufactures and supplies fine decorative framed mirrors, framed arts, and bathroom vanities. The company was incorporated in 2019 and is headquartered in Mount Vernon, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 40,718 102.18% | 20,140 72.61% | ||||
Cost of revenue | 33,444 | 31,225 | ||||
Unusual Expense (Income) | ||||||
NOPBT | 7,274 | (11,085) | ||||
NOPBT Margin | 17.86% | |||||
Operating Taxes | 5,475 | |||||
Tax Rate | ||||||
NOPAT | 7,274 | (16,560) | ||||
Net income | (13,204) -40.12% | (22,050) 198.36% | ||||
Dividends | (769) | (1,449) | ||||
Dividend yield | 87.99% | 12.55% | ||||
Proceeds from repurchase of equity | 11,625 | 1,872 | ||||
BB yield | -1,329.28% | -16.22% | ||||
| Debt | ||||||
Debt current | 2,577 | 3,799 | ||||
Long-term debt | 9,163 | 8,878 | ||||
Deferred revenue | ||||||
Other long-term liabilities | 91 | |||||
Net debt | 10,609 | 9,943 | ||||
| Cash flow | ||||||
Cash from operating activities | (7,845) | (8,736) | ||||
CAPEX | (560) | (24) | ||||
Cash from investing activities | (4,842) | (176) | ||||
Cash from financing activities | 11,083 | 2,879 | ||||
FCF | 18,155 | (21,597) | ||||
| Balance | ||||||
Cash | 1,131 | 2,734 | ||||
Long term investments | ||||||
Excess cash | 1,727 | |||||
Stockholders' equity | (38,284) | (28,236) | ||||
Invested Capital | 71,375 | 56,329 | ||||
ROIC | 11.39% | |||||
ROCE | 21.98% | |||||
| EV | ||||||
Common stock shares outstanding | 371 | 102 | ||||
Price | 2.36 -97.91% | 113.11 -66.49% | ||||
Market cap | 875 -92.42% | 11,542 -53.90% | ||||
EV | 16,260 | 21,485 | ||||
EBITDA | 11,316 | (7,879) | ||||
EV/EBITDA | 1.44 | |||||
Interest | 1,742 | 290 | ||||
Interest/NOPBT | 23.95% | |||||